Frispas P (20+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Invision Medi Sciences. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Dicyclomine Hydrochloride. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 22 (arround $0.308 US Dollar)
Generic (Salt) Combination :
(Paracetamol+ Dicyclomine Hydrochloride)
Pharma Company :
Invision Medi Sciences
Brand Label :
Frispas P (20+500)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Paracetamol-500 mg
Dicyclomine Hydrochloride-20 mg
Pack Size/Qty/Vol :
10 Tablet
Price Unit :
Rs 2.2 INR (arround $0.0308 US Dollar)
Price Pack :
Rs 22 INR (arround $0.308 US Dollar)
Drug details for Frispas P (20+500)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Frispas P (20+500) are :
Paracetamol-500 mg
Dicyclomine Hydrochloride-20 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Dicyclomine Hydrochloride Indication (Prescribed for or used as):
For more details on Dicyclomine Hydrochloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dicyclomine Hydrochloride..
Frispas P (20+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 17 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Frispas P (20+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Paracetamol-500 mg Dicyclomine Hydrochloride-20 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.